Ind-Swift Laboratories Limited has informed the Exchange regarding Intimation under Regulation 57(5) of SEBI (LODR), Regulations, 2015..
JSW Ispat Special Products Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
RSWM Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Dharani Sugars & Chemicals Limited
A2Z Infra Engineering Limited has informed the Exchange regarding Grant of 1448000 Options.
Tata Motors Limited has informed the Exchange regarding a press release dated January 04, 2022, titled Tata Motors SIAM Report October to December 2021.
Hind Rectifiers Limited has informed the Exchange regarding Intimation to the Shareholders holding shares in Physical Mode.
Chambal Fertilizers & Chemicals Limited has informed the Exchange about Loss of Share Certificates
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 04, 2022, titled Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Hyclate Delayed-Release Tablets USP, 75 mg, 100 mg, 150 mg, and 200 mg.
Orient Bell Limited has informed the Exchange regarding Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.12.2021..

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.